Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents development of atherosclerosis in high-fat diet-fed apoE-deficient mice via ameliorating hyperlipidemia, pro-inflammatory mediators and oxidative responses

Documenti analoghi

• Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents metabolic dysfunction and Alzheimer's disease-related memory loss in senescence-accelerated prone 8 (SAMP8) mice fed a high-fat diet.
  di: Yutaro Kobayashi, et al.
  Pubblicazione: (2018-01-01)
• Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents metabolic dysfunction and Alzheimer’s disease-related memory loss in senescence-accelerated prone 8 (SAMP8) mice fed a high-fat diet
  di: Kobayashi, Yutaro, et al.
  Pubblicazione: (2018)
• Pantoea agglomerans lipopolysaccharide maintains bone density in premenopausal women: a randomized, double-blind, placebo-controlled trial
  di: Nakata, Kazue, et al.
  Pubblicazione: (2014)
• Genome Sequence of Pantoea agglomerans Strain IG1
  di: Matsuzawa, Tomohiko, et al.
  Pubblicazione: (2012)
• Effects of 3 months continuous intake of supplement containing Pantoea agglomerans LPS to maintain normal bloodstream in adults: Parallel double‐blind randomized controlled study
  di: Nakata, Yoko, et al.
  Pubblicazione: (2017)